Published in Neurobiol Aging on September 15, 2010
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2011) 4.25
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2013) 2.32
Mitochondrial haplotypes associated with biomarkers for Alzheimer's disease. PLoS One (2013) 1.47
The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochim Biophys Acta (2013) 1.34
Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers. Brain Imaging Behav (2014) 1.23
Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology (2011) 1.23
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. Alzheimers Dement (2015) 1.03
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents. Neurobiol Aging (2012) 0.96
Structural brain changes in normal individuals with a maternal history of Alzheimer's. Neurobiol Aging (2011) 0.94
Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging (2013) 0.91
Brain imaging of cognitively normal individuals with 2 parents affected by late-onset AD. Neurology (2014) 0.88
Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis. US Neurol (2010) 0.86
FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts? Q J Nucl Med Mol Imaging (2011) 0.86
Recent advances in imaging Alzheimer's disease. J Alzheimers Dis (2013) 0.85
Maternal family history is associated with Alzheimer's disease biomarkers. J Alzheimers Dis (2012) 0.84
Alzheimer disease: 'generation next' in Alzheimer disease genetic studies. Nat Rev Neurol (2013) 0.82
Prevalence of Alzheimer's pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives. PLoS One (2013) 0.82
Maternal transmission of Alzheimer disease. Alzheimer Dis Assoc Disord (2012) 0.81
Cerebral atrophy in mild cognitive impairment: A systematic review with meta-analysis. Alzheimers Dement (Amst) (2015) 0.80
Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease. Neurobiol Aging (2011) 0.79
Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring. Neurobiol Aging (2015) 0.77
Apolipoprotein E epsilon 4 allele is associated with ventricular expansion rate and surface morphology in dementia and normal aging. Neurobiol Aging (2013) 0.77
Brain atrophy rates in first degree relatives at risk for Alzheimer's. Neuroimage Clin (2014) 0.76
The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism. Alzheimers Dement (Amst) (2016) 0.75
Improved Diagnostic Multimodal Biomarkers for Alzheimer's Disease and Mild Cognitive Impairment. Biomed Res Int (2015) 0.75
Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial. BMC Neurol (2016) 0.75
Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration. Front Immunol (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology (1993) 47.72
A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging (1998) 23.54
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69
Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr (1994) 15.38
Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol (2003) 14.87
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging (2008) 14.68
A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci (2001) 10.38
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet (2007) 9.80
Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage (2005) 8.50
Alzheimer's disease. N Engl J Med (2004) 7.50
The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am (2005) 7.26
Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage (2004) 5.07
Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology (2000) 4.89
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci (2008) 4.64
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology (1998) 3.90
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage (2006) 3.85
Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med (1997) 3.74
Mitochondrial disease. Lancet (2006) 3.38
Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA (2002) 3.16
Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol (2006) 3.11
Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study. Genet Med (2004) 2.82
Changes in hippocampal volume and shape across time distinguish dementia of the Alzheimer type from healthy aging. Neuroimage (2003) 2.77
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain (2006) 2.73
Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging (1997) 2.68
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology (2008) 2.66
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol (1998) 2.53
Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci U S A (2007) 2.41
Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type. Neurology (2000) 2.31
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.30
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28
A full genome scan for late onset Alzheimer's disease. Hum Mol Genet (1999) 2.26
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.25
Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal. Neurobiol Aging (2008) 2.25
New frontiers in Alzheimer's disease genetics. Neuron (2001) 2.17
Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields. Hippocampus (2009) 2.08
Association of parental dementia with cognitive and brain MRI measures in middle-aged adults. Neurology (2009) 1.94
Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol (2005) 1.91
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology (2009) 1.88
Regional specificity of hippocampal volume reductions in first-episode schizophrenia. Neuroimage (2004) 1.87
DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet (2006) 1.73
Genome-wide association studies in Alzheimer's disease. Hum Mol Genet (2009) 1.70
Variability of familial risk of Alzheimer disease across the late life span. Arch Gen Psychiatry (2005) 1.63
Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance. Neurology (1996) 1.59
Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T. Neuroimage (2008) 1.49
Computational anatomical methods as applied to ageing and dementia. Br J Radiol (2007) 1.45
Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology (2010) 1.41
Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment. Neurology (2007) 1.33
Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment. Neuropsychologia (2007) 1.26
Genetic epidemiological study of maternal and paternal transmission of Alzheimer's disease. Am J Med Genet (1999) 1.09
Non-apolipoprotein E and apolipoprotein E genetics of sporadic Alzheimer's disease. Ageing Res Rev (2009) 0.98
Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease. Neurobiol Aging (2006) 0.94
Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease. J Alzheimers Dis (2006) 0.93
Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? Curr Alzheimer Res (2008) 0.92
Initial results of a genome survey for novel Alzheimer's disease risk genes: association with a locus on the X chromosome. Am J Med Genet (1998) 0.81
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc (2005) 27.90
Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A (2004) 17.86
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
Mild cognitive impairment. Lancet (2006) 10.21
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Mapping cortical change across the human life span. Nat Neurosci (2003) 8.98
Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol (2010) 8.74
Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement (2005) 7.90
Longitudinal mapping of cortical thickness and brain growth in normal children. J Neurosci (2004) 7.30
The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am (2005) 7.26
Construction of a 3D probabilistic atlas of human cortical structures. Neuroimage (2007) 7.04
Dynamics of gray matter loss in Alzheimer's disease. J Neurosci (2003) 7.03
Stereotaxic white matter atlas based on diffusion tensor imaging in an ICBM template. Neuroimage (2008) 6.58
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
PET of brain amyloid and tau in mild cognitive impairment. N Engl J Med (2006) 6.02
Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage (2007) 5.86
The LONI Pipeline Processing Environment. Neuroimage (2003) 5.47
Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage (2004) 5.07
Mapping brain asymmetry. Nat Rev Neurosci (2003) 4.99
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2011) 4.25
Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res (2002) 4.17
Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res (2004) 4.15
Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci (2004) 4.14
Mapping cortical change in Alzheimer's disease, brain development, and schizophrenia. Neuroimage (2004) 4.13
Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res (2009) 3.86
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage (2006) 3.85
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage (2009) 3.74
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Dynamics of the hippocampus during encoding and retrieval of face-name pairs. Science (2003) 3.67
Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol (2003) 3.62
Mapping brain maturation. Trends Neurosci (2006) 3.60
Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage (2008) 3.40
Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol (2013) 3.32
A multimodal, multidimensional atlas of the C57BL/6J mouse brain. J Anat (2004) 3.28
Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (2002) 3.26
Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol (2003) 3.26
Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age. Cereb Cortex (2006) 3.23
Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol (2006) 3.11
Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement (2010) 3.11
Brain structure and obesity. Hum Brain Mapp (2010) 3.04
Genus zero surface conformal mapping and its application to brain surface mapping. IEEE Trans Med Imaging (2004) 2.93
Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum (2007) 2.90
A proposal for a coordinated effort for the determination of brainwide neuroanatomical connectivity in model organisms at a mesoscopic scale. PLoS Comput Biol (2009) 2.88
Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement (2010) 2.88
Mapping changes in the human cortex throughout the span of life. Neuroscientist (2004) 2.86
Human brain white matter atlas: identification and assignment of common anatomical structures in superficial white matter. Neuroimage (2008) 2.86
Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res (2008) 2.81
Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci U S A (2005) 2.79
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement (2010) 2.79
CUDA optimization strategies for compute- and memory-bound neuroimaging algorithms. Comput Methods Programs Biomed (2010) 2.75
3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain (2006) 2.73
Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet (2003) 2.71
Voxelwise genome-wide association study (vGWAS). Neuroimage (2010) 2.69
3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry. Neuroimage (2006) 2.69
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement (2010) 2.68
Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cereb Cortex (2004) 2.66
The topography of grey matter involvement in early and late onset Alzheimer's disease. Brain (2007) 2.53
Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage (2005) 2.51
Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Arch Gen Psychiatry (2005) 2.48
Genetics of brain fiber architecture and intellectual performance. J Neurosci (2009) 2.42
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage (2008) 2.40
Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer. Gut (2011) 2.38
Towards multimodal atlases of the human brain. Nat Rev Neurosci (2006) 2.37
Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function. Hum Brain Mapp (2007) 2.36
Statistical properties of Jacobian maps and the realization of unbiased large-deformation nonlinear image registration. IEEE Trans Med Imaging (2007) 2.33
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement (2013) 2.32
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.30
Senescence rates are determined by ranking on the fast-slow life-history continuum. Ecol Lett (2008) 2.30
Efficient, Distributed and Interactive Neuroimaging Data Analysis Using the LONI Pipeline. Front Neuroinform (2009) 2.29
Provenance in neuroimaging. Neuroimage (2008) 2.28